The psoriasis drug Stelara could also help with Crohn’s disease.
Based on the findings of a recent study, researchers from the University of California, San Diego School of Medicine suggest that the psoriasis drug Stelara may also be effective against Crohn’s disease.
This drug, which is used to treat the skin condition psoriasis, is marketed by Johnson & Johnson.
As per Dr. Bruce Sands, professor of medicine at the Mount Sinai School of Medicine in New York City, the recent study confirms the findings of an earlier experiment that also suggested that Stelara could effectively fight Crohn’s disease.
Currently, approximately 700,000 Americans have Crohn’s disease, a condition that can cause intestinal bleeding, diarrhea, weight loss, bowel obstruction, and intestinal abscesses.
As there is currently no known cure for Crohn’s, the results of the study offer new hope for individuals suffering from hard-to-treat Crohn’s disease, and the research team views this finding as a step in the right direction.
According to Dr. William Sandborn, lead author of the study, chief of the division of gastroenterology at the UC San Diego School of Medicine, one of the biggest challenges to finding a treatment for Crohn’s disease is that almost one-third of the patients are resistant to some of the common TNF (tumor necrosis factor) inhibitors. These TNF inhibitors help regulate inflammation and also help regulate the body’s immune system. Of the remaining two-thirds, half of patients respond to TNF inhibitors very minimally. Which means, close to 70 percent of the patients don’t respond well to these drugs.
Read Full Article: Psoriasis drug may be effective against Crohn’s disease: Study
|Read Full Article: Psoriasis drug may be effective against Crohn’s disease: Study|